424 related articles for article (PubMed ID: 28243062)
1. Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals.
Rajabalaya R; Musa MN; Kifli N; David SR
Drug Des Devel Ther; 2017; 11():393-406. PubMed ID: 28243062
[TBL] [Abstract][Full Text] [Related]
2. Oral Drug Delivery via Intestinal Lymphatic Transport Utilizing Lipid-Based Lyotropic Liquid Crystals.
Dinh L; Yan B
Liquids (Basel); 2023 Dec; 3(4):456-468. PubMed ID: 38711572
[TBL] [Abstract][Full Text] [Related]
3. Interactions of biomacromolecules with reverse hexagonal liquid crystals: drug delivery and crystallization applications.
Libster D; Aserin A; Garti N
J Colloid Interface Sci; 2011 Apr; 356(2):375-86. PubMed ID: 21315366
[TBL] [Abstract][Full Text] [Related]
4. Advances in lyotropic liquid crystal systems for skin drug delivery.
Silvestrini AVP; Caron AL; Viegas J; Praça FG; Bentley MVLB
Expert Opin Drug Deliv; 2020 Dec; 17(12):1781-1805. PubMed ID: 32886531
[TBL] [Abstract][Full Text] [Related]
5. Lyotropic liquid crystalline phases: Drug delivery and biomedical applications.
Chavda VP; Dyawanapelly S; Dawre S; Ferreira-Faria I; Bezbaruah R; Rani Gogoi N; Kolimi P; Dave DJ; Paiva-Santos AC; Vora LK
Int J Pharm; 2023 Nov; 647():123546. PubMed ID: 37884213
[TBL] [Abstract][Full Text] [Related]
6. Lyotropic liquid crystal-based transcutaneous peptide delivery system: Evaluation of skin permeability and potential for transcutaneous vaccination.
Kozaka S; Wakabayashi R; Kamiya N; Goto M
Acta Biomater; 2022 Jan; 138():273-284. PubMed ID: 34774785
[TBL] [Abstract][Full Text] [Related]
7. Cubic and hexagonal liquid crystals as drug delivery systems.
Chen Y; Ma P; Gui S
Biomed Res Int; 2014; 2014():815981. PubMed ID: 24995330
[TBL] [Abstract][Full Text] [Related]
8. A Novel Chemical Enhancer Approach for Transdermal Drug Delivery with C
Kadhum WR; Sekiguchi S; Hijikuro I; Todo H; Sugibayashi K
J Oleo Sci; 2017 May; 66(5):443-454. PubMed ID: 28381773
[TBL] [Abstract][Full Text] [Related]
9. On the Structure and Transdermal Profile of Liquid Crystals Based on Phytantriol.
Chu XQ; Huang J; Li ZG; Li Q; Cao JJ; Jiang JQ; Gui SY
Curr Drug Deliv; 2018; 15(10):1439-1448. PubMed ID: 30198435
[TBL] [Abstract][Full Text] [Related]
10. Lipid polymorphism in lyotropic liquid crystals for triggered release of bioactives.
Garti N; Libster D; Aserin A
Food Funct; 2012 Jul; 3(7):700-13. PubMed ID: 22592749
[TBL] [Abstract][Full Text] [Related]
11. Oil and drug control the release rate from lyotropic liquid crystals.
Martiel I; Baumann N; Vallooran JJ; Bergfreund J; Sagalowicz L; Mezzenga R
J Control Release; 2015 Apr; 204():78-84. PubMed ID: 25744826
[TBL] [Abstract][Full Text] [Related]
12. Nanostructured cubosomes as advanced drug delivery system.
Pan X; Han K; Peng X; Yang Z; Qin L; Zhu C; Huang X; Shi X; Dian L; Lu M; Wu C
Curr Pharm Des; 2013; 19(35):6290-7. PubMed ID: 23470001
[TBL] [Abstract][Full Text] [Related]
13. Glycerol monooleate liquid crystalline phases used in drug delivery systems.
Milak S; Zimmer A
Int J Pharm; 2015 Jan; 478(2):569-87. PubMed ID: 25479099
[TBL] [Abstract][Full Text] [Related]
14. Lipidic lyotropic liquid crystals: Insights on biomedical applications.
Blanco-Fernández G; Blanco-Fernandez B; Fernández-Ferreiro A; Otero-Espinar FJ
Adv Colloid Interface Sci; 2023 Mar; 313():102867. PubMed ID: 36889183
[TBL] [Abstract][Full Text] [Related]
15. Nanostructured liquid-crystalline particles for drug delivery.
Lancelot A; Sierra T; Serrano JL
Expert Opin Drug Deliv; 2014 Apr; 11(4):547-64. PubMed ID: 24490701
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Lipid-Based Lyotropic Liquid Crystal and Effects of Guest Molecules on Its Microstructure: a Systematic Review.
Wang X; Zhang Y; Gui S; Huang J; Cao J; Li Z; Li Q; Chu X
AAPS PharmSciTech; 2018 Jul; 19(5):2023-2040. PubMed ID: 29869308
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a Liquid Crystal System for Sustained Release of a Peptide BMS-686117.
Xu Y; Li V; Li J; Pan D; Langenbucher G; Mathias N
AAPS PharmSciTech; 2018 Jan; 19(1):348-357. PubMed ID: 28741139
[TBL] [Abstract][Full Text] [Related]
18. Spotlight on Biomimetic Systems Based on Lyotropic Liquid Crystal.
de Souza JF; Pontes KD; Alves TF; Amaral VA; Rebelo MA; Hausen MA; Chaud MV
Molecules; 2017 Mar; 22(3):. PubMed ID: 28272377
[TBL] [Abstract][Full Text] [Related]
19. Formulation and characterization of liquid crystal systems containing azelaic acid for topical delivery.
Aytekin M; Gursoy RN; Ide S; Soylu EH; Hekimoglu S
Drug Dev Ind Pharm; 2013 Feb; 39(2):228-39. PubMed ID: 22480294
[TBL] [Abstract][Full Text] [Related]
20. Lyotropic liquid crystals for parenteral drug delivery.
Chavda VP; Dawre S; Pandya A; Vora LK; Modh DH; Shah V; Dave DJ; Patravale V
J Control Release; 2022 Sep; 349():533-549. PubMed ID: 35792188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
